07/02/2026
CBD, Pain Perception, and TRPV Receptors
The mechanisms by which CBD may be able act as a pain reliever are not entirely known. Nevertheless, due to mass legalization of h**p in America, Cannabidiol (CBD) is emerging as a promising agent for managing symptoms of pain, inflammation, seizures, and anxiety. For the same reasons, patients are able to try CBD over the counter. Many report subsequent relief from pain and inflammation.
Animals studies indicate that CBD has action on receptors in the endocannbinoid system and nociceptive (pain sensing) system. Research published in the Journal of Pain Research (2020) [4] showed that CBD interaction with TRPV receptors is likely to be the reason for this pain relief. The exact mechanisms, however, remain unknown.

Hope for the Future of Cannabis-Cancer Research
Although the TRPV1 studies, as well as other in vitro cancer studies, show promise for cannabinoids like CBD, AEA, and THC, we must remember that these studies are early stage. Cancer cells don’t behave the same way in test tubes as they do in the human body. Although cannabis may work wonders for killing cancer cells in a laboratory, a cannabinoid-based therapy may be much more complicated in reality.
Unfortunately, prohibition and other legislative restrictions continue to hamper cannabis research .
It’s long overdue.
